Artificial Intelligence in Brain Diseases

A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Machine Learning and Artificial Intelligence in Diagnostics".

Deadline for manuscript submissions: 31 December 2024 | Viewed by 4603

Special Issue Editor

The College of Electrical Engineering, Sichuan University, Chengdu 610065, China
Interests: machine learning; brain; LSTM; artificial intelligence; load forecasting; image segmentation
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

The application of artificial intelligence in brain disease diagnosis and treatment planning is developing with increasing speed and has proved to be an effective tool for the early screening of brain tumors and cerebral hemorrhage as well as for the PTV delineation of radio therapy and radiosurgery. Notable publicly accessible datasets are available for the design, validation, and comparison of corresponding algorithms. Some of them act as a benchmark in the field—for example, the dataset from the MICCAI Brain Tumor Segmentation (BraTS) Challenge and the dataset from Ischemic Stroke Lesion Segmentation (ISLES). Additionally, the Alzheimer’s Disease Neuroimaging Initiative (ADNI) dataset provides researchers a way to apply their methods to functional brain image analysis.

Inspired by these exciting achievements, we are organizing this Special Issue on Artificial Intelligence and Imaging in Brain Diseases. We warmly invite researchers worldwide to submit their original research articles in the field.

Dr. Yan Liu
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (4 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

23 pages, 5030 KiB  
Article
A Feature-Fusion Technique-Based Alzheimer’s Disease Classification Using Magnetic Resonance Imaging
by Abdul Rahaman Wahab Sait and Ramprasad Nagaraj
Diagnostics 2024, 14(21), 2363; https://doi.org/10.3390/diagnostics14212363 - 23 Oct 2024
Viewed by 532
Abstract
Background: Early identification of Alzheimer’s disease (AD) is essential for optimal treatment and management. Deep learning (DL) technologies, including convolutional neural networks (CNNs) and vision transformers (ViTs) can provide promising outcomes in AD diagnosis. However, these technologies lack model interpretability and demand substantial [...] Read more.
Background: Early identification of Alzheimer’s disease (AD) is essential for optimal treatment and management. Deep learning (DL) technologies, including convolutional neural networks (CNNs) and vision transformers (ViTs) can provide promising outcomes in AD diagnosis. However, these technologies lack model interpretability and demand substantial computational resources, causing challenges in the resource-constrained environment. Hybrid ViTs can outperform individual ViTs by visualizing key features with limited computational power. This synergy enhances feature extraction and promotes model interpretability. Objectives: Thus, the authors present an innovative model for classifying AD using MRI images with limited computational resources. Methods: The authors improved the AD feature-extraction process by modifying the existing ViTs. A CatBoost-based classifier was used to classify the extracted features into multiple classes. Results: The proposed model was generalized using the OASIS dataset. The model obtained an exceptional classification accuracy of 98.8% with a minimal loss of 0.12. Conclusions: The findings highlight the potential of the proposed AD classification model in providing an interpretable and resource-efficient solution for healthcare centers. To improve model robustness and applicability, subsequent research can include genetic and clinical data. Full article
(This article belongs to the Special Issue Artificial Intelligence in Brain Diseases)
Show Figures

Figure 1

33 pages, 18210 KiB  
Article
Ultrafast Brain MRI at 3 T for MS: Evaluation of a 51-Second Deep Learning-Enhanced T2-EPI-FLAIR Sequence
by Martin Schuhholz, Christer Ruff, Eva Bürkle, Thorsten Feiweier, Bryan Clifford, Markus Kowarik and Benjamin Bender
Diagnostics 2024, 14(17), 1841; https://doi.org/10.3390/diagnostics14171841 - 23 Aug 2024
Viewed by 983
Abstract
In neuroimaging, there is no equivalent alternative to magnetic resonance imaging (MRI). However, image acquisitions are generally time-consuming, which may limit utilization in some cases, e.g., in patients who cannot remain motionless for long or suffer from claustrophobia, or in the event of [...] Read more.
In neuroimaging, there is no equivalent alternative to magnetic resonance imaging (MRI). However, image acquisitions are generally time-consuming, which may limit utilization in some cases, e.g., in patients who cannot remain motionless for long or suffer from claustrophobia, or in the event of extensive waiting times. For multiple sclerosis (MS) patients, MRI plays a major role in drug therapy decision-making. The purpose of this study was to evaluate whether an ultrafast, T2-weighted (T2w), deep learning-enhanced (DL), echo-planar-imaging-based (EPI) fluid-attenuated inversion recovery (FLAIR) sequence (FLAIRUF) that has targeted neurological emergencies so far might even be an option to detect MS lesions of the brain compared to conventional FLAIR sequences. Therefore, 17 MS patients were enrolled prospectively in this exploratory study. Standard MRI protocols and ultrafast acquisitions were conducted at 3 tesla (T), including three-dimensional (3D)-FLAIR, turbo/fast spin-echo (TSE)-FLAIR, and FLAIRUF. Inflammatory lesions were grouped by size and location. Lesion conspicuity and image quality were rated on an ordinal five-point Likert scale, and lesion detection rates were calculated. Statistical analyses were performed to compare results. Altogether, 568 different lesions were found. Data indicated no significant differences in lesion detection (sensitivity and positive predictive value [PPV]) between FLAIRUF and axially reconstructed 3D-FLAIR (lesion size ≥3 mm × ≥2 mm) and no differences in sensitivity between FLAIRUF and TSE-FLAIR (lesion size ≥3 mm total). Lesion conspicuity in FLAIRUF was similar in all brain regions except for superior conspicuity in the occipital lobe and inferior conspicuity in the central brain regions. Further findings include location-dependent limitations of signal-to-noise ratio (SNR) and contrast-to-noise ratio (CNR) as well as artifacts such as spatial distortions in FLAIRUF. In conclusion, FLAIRUF could potentially be an expedient alternative to conventional methods for brain imaging in MS patients since the acquisition can be performed in a fraction of time while maintaining good image quality. Full article
(This article belongs to the Special Issue Artificial Intelligence in Brain Diseases)
Show Figures

Figure 1

26 pages, 4472 KiB  
Article
EEG-Based Detection of Mild Cognitive Impairment Using DWT-Based Features and Optimization Methods
by Majid Aljalal, Saeed A. Aldosari, Khalil AlSharabi and Fahd A. Alturki
Diagnostics 2024, 14(15), 1619; https://doi.org/10.3390/diagnostics14151619 - 26 Jul 2024
Cited by 1 | Viewed by 829
Abstract
In recent years, electroencephalography (EEG) has been investigated for identifying brain disorders. This technique involves placing multiple electrodes (channels) on the scalp to measure the brain’s activities. This study focuses on accurately detecting mild cognitive impairment (MCI) from the recorded EEG signals. To [...] Read more.
In recent years, electroencephalography (EEG) has been investigated for identifying brain disorders. This technique involves placing multiple electrodes (channels) on the scalp to measure the brain’s activities. This study focuses on accurately detecting mild cognitive impairment (MCI) from the recorded EEG signals. To achieve this, this study first introduced discrete wavelet transform (DWT)-based approaches to generate reliable biomarkers for MCI. These approaches decompose each channel’s signal using DWT into a set of distinct frequency band signals, then extract features using a non-linear measure such as band power, energy, or entropy. Various machine learning approaches then classify the generated features. We investigated these methods on EEGs recorded using 19 channels from 29 MCI patients and 32 healthy subjects. In the second step, the study explored the possibility of decreasing the number of EEG channels while preserving, or even enhancing, classification accuracy. We employed multi-objective optimization techniques, such as the non-dominated sorting genetic algorithm (NSGA) and particle swarm optimization (PSO), to achieve this. The results show that the generated DWT-based features resulted in high full-channel classification accuracy scores. Furthermore, selecting fewer channels carefully leads to better accuracy scores. For instance, with a DWT-based approach, the full-channel accuracy achieved was 99.84%. With only four channels selected by NSGA-II, NSGA-III, or PSO, the accuracy increased to 99.97%. Furthermore, NSGA-II selects five channels, achieving an accuracy of 100%. The results show that the suggested DWT-based approaches are promising to detect MCI, and picking the most useful EEG channels makes the accuracy even higher. The use of a small number of electrodes paves the way for EEG-based diagnosis in clinical practice. Full article
(This article belongs to the Special Issue Artificial Intelligence in Brain Diseases)
Show Figures

Figure 1

10 pages, 1391 KiB  
Article
Deep Learning Network with Spatial Attention Module for Detecting Acute Bilirubin Encephalopathy in Newborns Based on Multimodal MRI
by Huan Zhang, Yi Zhuang, Shunren Xia and Haoxiang Jiang
Diagnostics 2023, 13(9), 1577; https://doi.org/10.3390/diagnostics13091577 - 28 Apr 2023
Viewed by 1626
Abstract
Background: Acute bilirubin encephalopathy (ABE) is a significant cause of neonatal mortality and disability. Early detection and treatment of ABE can prevent the further development of ABE and its long-term complications. Due to the limited classification ability of single-modal magnetic resonance imaging (MRI), [...] Read more.
Background: Acute bilirubin encephalopathy (ABE) is a significant cause of neonatal mortality and disability. Early detection and treatment of ABE can prevent the further development of ABE and its long-term complications. Due to the limited classification ability of single-modal magnetic resonance imaging (MRI), this study aimed to validate the classification performance of a new deep learning model based on multimodal MRI images. Additionally, the study evaluated the effect of a spatial attention module (SAM) on improving the model’s diagnostic performance in distinguishing ABE. Methods: This study enrolled a total of 97 neonates diagnosed with ABE and 80 neonates diagnosed with hyperbilirubinemia (HB, non-ABE). Each patient underwent three types of multimodal imaging, which included T1-weighted imaging (T1WI), T2-weighted imaging (T2WI), and an apparent diffusion coefficient (ADC) map. A multimodal MRI classification model based on the ResNet18 network with spatial attention modules was built to distinguish ABE from non-ABE. All combinations of the three types of images were used as inputs to test the model’s classification performance, and we also analyzed the prediction performance of models with SAMs through comparative experiments. Results: The results indicated that the diagnostic performance of the multimodal image combination was better than any single-modal image, and the combination of T1WI and T2WI achieved the best classification performance (accuracy = 0.808 ± 0.069, area under the curve = 0.808 ± 0.057). The ADC images performed the worst among the three modalities’ images. Adding spatial attention modules significantly improved the model’s classification performance. Conclusion: Our experiment showed that a multimodal image classification network with spatial attention modules significantly improved the accuracy of ABE classification. Full article
(This article belongs to the Special Issue Artificial Intelligence in Brain Diseases)
Show Figures

Figure 1

Back to TopTop